95 results
Page 2 of 5
6-K
EX-99.1
ui33n9r77iapuzs4lx
27 Oct 23
XORTX Announces Results of Special Meeting of Shareholders
6:05pm
6-K
EX-99.1
dk562er8ld8xgh0rtoa1
12 Oct 23
XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation Resolution
7:41am
6-K
EX-99.2
d8s58o3fdo p9nuy
4 Oct 23
Notice of Special Meeting of Shareholders
7:00am
6-K
EX-99.1
apu6oq7952rdoddbv
29 Aug 23
XORTX Submits Orphan Drug Designation Application to the European Medicines Agency (EMA) to Treat Progressive Kidney Disease
7:00am
424B3
kag0lg wlb
25 Aug 23
Prospectus supplement
6:00am
424B3
as48iy6hj4w9
25 Aug 23
Prospectus supplement
6:00am
6-K
EX-99.1
y5ot2qz6ngirtbt
15 Aug 23
Condensed Interim Consolidated Financial Statements
6:00am
6-K
EX-99.2
kmxuvxu ncoumpyl
15 Aug 23
Condensed Interim Consolidated Financial Statements
6:00am
424B3
ie77pt
14 Aug 23
Prospectus supplement
4:42pm
424B3
mm7 8apoy
14 Aug 23
Prospectus supplement
4:40pm
POS AM
oyb87q
4 Aug 23
Prospectus update (post-effective amendment)
4:08pm
POS AM
fiv s548spavuzupjqs
4 Aug 23
Prospectus update (post-effective amendment)
4:05pm
6-K
EX-99.1
cjsvid
6 Jun 23
XORTX Announces PKD Presentation
7:00am
6-K
EX-99.2
dchcv 6oascm
30 May 23
Notice of Annual & Special Meeting of Shareholders
7:00am
6-K
EX-99.1
th4jv60ltk a74s07zxf
16 May 23
Condensed Interim Consolidated Financial Statements
9:32am
6-K
EX-99.2
20t9w1w9djq1f8acqgl9
16 May 23
Condensed Interim Consolidated Financial Statements
9:32am